speb/financial-data huggingface dataset:
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 22639530490.64
JCARE.SW income_statement (annual, 2023-12-31) — Total Expenses: 13269294870.61
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 13718595768.18
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 12483495868.42
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 3857907922.66
JCARE.SW income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 3506565173.51
JCARE.SW income_statement (annual, 2023-12-31) — Total Other Finance Cost: 7933365.27
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Tax Payable: 410202854.09
JCARE.SW income_statement (annual, 2023-12-31) — Total Unusual Items: -355474828.37
JCARE.SW income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -355474828.37
JCARE.SW balance_sheet (annual, 2023-12-31) — Work In Process: 668672930.34
JCARE.SW balance_sheet (annual, 2023-12-31) — Working Capital: 14013942544.88
JCARE.SW income_statement (annual, 2023-12-31) — Write Off: 16846468.56
JCARE.SW balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 90000000.00
JCARE.SW income_statement (annual, 2024-12-31) — +Operating Expense: 6269051274.01
JCARE.SW income_statement (quarterly, 2024-12-31) — +Operating Expense: 1559503018.76
JCARE.SW income_statement (annual, 2024-12-31) — +Total Revenue: 15619480306.89
JCARE.SW income_statement (quarterly, 2024-12-31) — +Total Revenue: 3720651401.87
JCARE.SW balance_sheet (annual, 2024-12-31) — Accounts Payable: 2150456140.40
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 2150456140.40
JCARE.SW balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2429891052.01
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 2429891052.01
JCARE.SW balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -6782405138.27
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -6782405138.27
JCARE.SW balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1175363032.47
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 1175363032.47
JCARE.SW balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -82315968.81
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -82315968.81
JCARE.SW cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 108055758.52
JCARE.SW balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 54029237.68
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 54029237.68
JCARE.SW balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 1026548743.15
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 1026548743.15
JCARE.SW income_statement (annual, 2024-12-31) — Basic Average Shares: 187374350.00
JCARE.SW income_statement (annual, 2024-12-31) — Basic EPS: 7.40
JCARE.SW cash_flow (annual, 2024-12-31) — Beginning Cash Position: 15340869372.73
JCARE.SW cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 14585469820.67
JCARE.SW cash_flow (annual, 2024-12-31) — Capital Expenditure: -979132035.36
JCARE.SW cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -242097097.53
JCARE.SW balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 19975819.77
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 19975819.77
JCARE.SW balance_sheet (annual, 2024-12-31) — Capital Stock: 1874200420.00
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1874200420.00
JCARE.SW balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 14851977121.94
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 14851977121.94
JCARE.SW balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 14941340177.01
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 14941340177.01
JCARE.SW cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -468148795.73
JCARE.SW cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: -28053094.31
JCARE.SW balance_sheet (annual, 2024-12-31) — Cash Equivalents: 126492936.86
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 126492936.86
JCARE.SW balance_sheet (annual, 2024-12-31) — Cash Financial: 14725484185.08
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Cash Financial: 14725484185.08
JCARE.SW cash_flow (annual, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: 3636320913.57
JCARE.SW cash_flow (quarterly, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: 1022715412.51
JCARE.SW cash_flow (annual, 2024-12-31) — Change In Inventory: -51290145.86
JCARE.SW cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -88621563.93
JCARE.SW cash_flow (annual, 2024-12-31) — Change In Payable: -493777927.35
JCARE.SW cash_flow (annual, 2024-12-31) — Change In Receivables: 122423878.33
JCARE.SW cash_flow (annual, 2024-12-31) — Change In Working Capital: -511265758.81
JCARE.SW cash_flow (annual, 2024-12-31) — Changes In Cash: -553708675.04
JCARE.SW cash_flow (quarterly, 2024-12-31) — Changes In Cash: 164264334.43
JCARE.SW cash_flow (annual, 2024-12-31) — Classesof Cash Payments: -12324046163.67
JCARE.SW cash_flow (quarterly, 2024-12-31) — Classesof Cash Payments: -2950922312.56
JCARE.SW cash_flow (annual, 2024-12-31) — Classesof Cash Receiptsfrom Operating Activities: 17825402550.37
JCARE.SW cash_flow (quarterly, 2024-12-31) — Classesof Cash Receiptsfrom Operating Activities: 4459913290.34
JCARE.SW balance_sheet (annual, 2024-12-31) — Common Stock: 1874200420.00
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Common Stock: 1874200420.00
JCARE.SW balance_sheet (annual, 2024-12-31) — Common Stock Equity: 14534719589.34
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 14534719589.34
JCARE.SW balance_sheet (annual, 2024-12-31) — Construction In Progress: 531063771.79
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 531063771.79
JCARE.SW income_statement (annual, 2024-12-31) — Cost Of Revenue: 5827852690.99
JCARE.SW income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1433933603.58
JCARE.SW balance_sheet (annual, 2024-12-31) — Current Assets: 23005860977.31
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Current Assets: 23005860977.31
JCARE.SW balance_sheet (annual, 2024-12-31) — Current Debt: 2455000000.00
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Current Debt: 2455000000.00
JCARE.SW balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2850975991.36
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 2850975991.36
JCARE.SW balance_sheet (annual, 2024-12-31) — Current Liabilities: 9270783051.69
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 9270783051.69
JCARE.SW cash_flow (annual, 2024-12-31) — Depreciation: 705263413.33
JCARE.SW cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 813319171.85
JCARE.SW income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 112160160.01
JCARE.SW income_statement (annual, 2024-12-31) — Depreciation Income Statement: 112160160.01
JCARE.SW income_statement (annual, 2024-12-31) — Diluted Average Shares: 187374350.00
JCARE.SW income_statement (annual, 2024-12-31) — Diluted EPS: 7.40
JCARE.SW balance_sheet (annual, 2024-12-31) — Dividends Payable: 9890041.38
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 9890041.38
JCARE.SW income_statement (annual, 2024-12-31) — EBIT: 3698148129.28
JCARE.SW income_statement (quarterly, 2024-12-31) — EBIT: 783860362.48
JCARE.SW income_statement (annual, 2024-12-31) — EBITDA: 4511467301.13
JCARE.SW income_statement (quarterly, 2024-12-31) — EBITDA: 783860362.48
JCARE.SW cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 55484980.63
JCARE.SW cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 92911523.22
JCARE.SW cash_flow (annual, 2024-12-31) — End Cash Position: 14842645678.32
JCARE.SW cash_flow (quarterly, 2024-12-31) — End Cash Position: 14842645678.32
JCARE.SW cash_flow (annual, 2024-12-31) — Financing Cash Flow: -3036022692.95
JCARE.SW cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -888405235.34
JCARE.SW balance_sheet (annual, 2024-12-31) — Finished Goods: 1138578483.78
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1138578483.78
JCARE.SW cash_flow (annual, 2024-12-31) — Free Cash Flow: 2657188878.21
JCARE.SW cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 780618314.98
JCARE.SW cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -46875634.39
JCARE.SW cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -37005073.65
JCARE.SW income_statement (annual, 2024-12-31) — General And Administrative Expense: 274588633.09
JCARE.SW income_statement (quarterly, 2024-12-31) — General And Administrative Expense: -434140984.75
JCARE.SW balance_sheet (annual, 2024-12-31) — Goodwill: 636339503.82
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Goodwill: 636339503.82
JCARE.SW balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1686473954.88
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 1686473954.88
JCARE.SW balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 2512207020.82
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 2512207020.82
JCARE.SW balance_sheet (annual, 2024-12-31) — Gross PPE: 13041311980.76
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Gross PPE: 13041311980.76
JCARE.SW income_statement (annual, 2024-12-31) — Gross Profit: 9791627615.90
JCARE.SW income_statement (quarterly, 2024-12-31) — Gross Profit: 2286717798.29
JCARE.SW income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 293144305.71
JCARE.SW income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 179450233.01
JCARE.SW income_statement (annual, 2024-12-31) — Interest Expense: 123261483.95
JCARE.SW income_statement (quarterly, 2024-12-31) — Interest Expense: 28288585.33
JCARE.SW income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 123261483.95
JCARE.SW income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 28288585.33
JCARE.SW income_statement (annual, 2024-12-31) — Interest Income: 417296591.13
JCARE.SW income_statement (quarterly, 2024-12-31) — Interest Income: 171311032.43
JCARE.SW income_statement (annual, 2024-12-31) — Interest Income Non Operating: 417296591.13
JCARE.SW income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 171311032.43
JCARE.SW balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: 0.00
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: 0.00
JCARE.SW balance_sheet (annual, 2024-12-31) — Inventory: 2621343117.50
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Inventory: 2621343117.50
JCARE.SW balance_sheet (annual, 2024-12-31) — Invested Capital: 19414354701.71
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Invested Capital: 19414354701.71
JCARE.SW cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1154006895.66
JCARE.SW cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 29954157.26
JCARE.SW balance_sheet (annual, 2024-12-31) — Investment Properties: 16117329.57
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Investment Properties: 16117329.57
JCARE.SW balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 1026548743.15
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 1026548743.15
JCARE.SW cash_flow (annual, 2024-12-31) — Issuance Of Debt: 6637402394.66
JCARE.SW cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 2906409242.24
JCARE.SW balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 19975819.77
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 19975819.77
JCARE.SW balance_sheet (annual, 2024-12-31) — Long Term Debt: 2424635112.37
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 2424635112.37
JCARE.SW balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2444610932.14
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2444610932.14
JCARE.SW cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 6637402394.66
JCARE.SW cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 2906409242.24
JCARE.SW cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -7276703823.63
JCARE.SW cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -2983506195.35
JCARE.SW balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 1446298598.46
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 1446298598.46
JCARE.SW balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 6637860823.32
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 6637860823.32
JCARE.SW balance_sheet (annual, 2024-12-31) — Minority Interest: 8865423189.94
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Minority Interest: 8865423189.94
JCARE.SW income_statement (annual, 2024-12-31) — Minority Interests: -1596175795.04
JCARE.SW income_statement (quarterly, 2024-12-31) — Minority Interests: -274039333.89
JCARE.SW income_statement (annual, 2024-12-31) — Net Income: 1386570192.56
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Income: 275010128.64
JCARE.SW income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1386570192.56
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 275010128.64
JCARE.SW income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 2982745987.60
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 549049462.53
JCARE.SW income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1386570192.56
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 275010128.64
JCARE.SW income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1386570192.56
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 275010128.64
JCARE.SW cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 2982745987.60
JCARE.SW income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 2982745987.60
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 549049462.53
JCARE.SW income_statement (annual, 2024-12-31) — Net Interest Income: 279105203.99
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Interest Income: 173135782.36
JCARE.SW cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -142956525.28
JCARE.SW cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 311431116.47
JCARE.SW cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -639301428.97
JCARE.SW cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -77096953.11
JCARE.SW cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -639301428.97
JCARE.SW cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -77096953.11
JCARE.SW income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 279105203.99
JCARE.SW income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 173135782.36
JCARE.SW cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -895505889.33
JCARE.SW cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -757500544.18
JCARE.SW cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -33417889.69
JCARE.SW cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -32013286.35
JCARE.SW balance_sheet (annual, 2024-12-31) — Net PPE: 6258906842.49
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Net PPE: 6258906842.49
JCARE.SW cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -977632480.69
JCARE.SW cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -241071672.86
JCARE.SW balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 12848245634.46
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 12848245634.46
JCARE.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 319396628.88
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 319396628.88
JCARE.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 334970008.52
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 334970008.52
JCARE.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 685468536.85
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 685468536.85
JCARE.SW balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 267622684.50
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 267622684.50
JCARE.SW income_statement (annual, 2024-12-31) — Normalized EBITDA: 4775147086.31
JCARE.SW income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 926942021.47
JCARE.SW income_statement (annual, 2024-12-31) — Normalized Income: 1606574321.16
JCARE.SW income_statement (quarterly, 2024-12-31) — Normalized Income: 378982921.62
JCARE.SW cash_flow (annual, 2024-12-31) — Operating Cash Flow: 3636320913.57
JCARE.SW income_statement (annual, 2024-12-31) — Operating Income: 3522576341.89
JCARE.SW income_statement (quarterly, 2024-12-31) — Operating Income: 727214779.53
JCARE.SW income_statement (annual, 2024-12-31) — Operating Revenue: 15619480306.89
JCARE.SW income_statement (quarterly, 2024-12-31) — Operating Revenue: 3720651401.87
JCARE.SW balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1874200420.00
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 1874200420.00
JCARE.SW cash_flow (annual, 2024-12-31) — Other Cash Paymentsfrom Operating Activities: -4849316960.56
JCARE.SW cash_flow (quarterly, 2024-12-31) — Other Cash Paymentsfrom Operating Activities: -1237851519.00
JCARE.SW cash_flow (annual, 2024-12-31) — Other Cash Receiptsfrom Operating Activities: 648241832.58
JCARE.SW cash_flow (quarterly, 2024-12-31) — Other Cash Receiptsfrom Operating Activities: 225975897.47
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Current Assets: 715498339.98
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 715498339.98
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 11841940.51
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 11841940.51
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1050134451.06
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 1050134451.06
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Inventories: 98002239.30
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Inventories: 98002239.30
JCARE.SW cash_flow (annual, 2024-12-31) — Other Non Cash Items: 153046402.83
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1273057844.54
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 1273057844.54
JCARE.SW income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -50356817.95
JCARE.SW income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -37288588.44
JCARE.SW income_statement (annual, 2024-12-31) — Other Operating Expenses: 213237688.57
JCARE.SW income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 75670446.54
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Payable: 3832796504.74
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Payable: 3832796504.74
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Properties: 1016979834.13
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Properties: 1016979834.13
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Receivables: 2002379839.34
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Receivables: 2002379839.34
JCARE.SW balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 89363055.07
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 89363055.07
JCARE.SW income_statement (annual, 2024-12-31) — Other Special Charges: -45262713.71
JCARE.SW income_statement (quarterly, 2024-12-31) — Other Special Charges: -45633112.75
JCARE.SW income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW balance_sheet (annual, 2024-12-31) — Payables: 6256523026.32
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Payables: 6256523026.32
JCARE.SW cash_flow (annual, 2024-12-31) — Paymentson Behalfof Employees: -2473862830.91
JCARE.SW cash_flow (quarterly, 2024-12-31) — Paymentson Behalfof Employees: -539957718.06
JCARE.SW cash_flow (annual, 2024-12-31) — Paymentsto Suppliersfor Goodsand Services: -5000866372.20
JCARE.SW cash_flow (quarterly, 2024-12-31) — Paymentsto Suppliersfor Goodsand Services: -1173113075.50
JCARE.SW balance_sheet (annual, 2024-12-31) — Prepaid Assets: 241379213.79
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 241379213.79
JCARE.SW income_statement (annual, 2024-12-31) — Pretax Income: 3574886645.33
JCARE.SW income_statement (quarterly, 2024-12-31) — Pretax Income: 755571777.15
JCARE.SW balance_sheet (annual, 2024-12-31) — Properties: 4855407551.52
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Properties: 4855407551.52
JCARE.SW cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1287596503.61
JCARE.SW cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -126948197.12
JCARE.SW cash_flow (annual, 2024-12-31) — Purchase Of PPE: -979132035.36
JCARE.SW cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -242097097.53
JCARE.SW balance_sheet (annual, 2024-12-31) — Raw Materials: 619529352.33
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Raw Materials: 619529352.33
JCARE.SW cash_flow (annual, 2024-12-31) — Receiptsfrom Customers: 17177160717.79
JCARE.SW cash_flow (quarterly, 2024-12-31) — Receiptsfrom Customers: 4233937392.87
JCARE.SW income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 5827852690.99
JCARE.SW income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1433933603.58
JCARE.SW income_statement (annual, 2024-12-31) — Reconciled Depreciation: 813319171.85
JCARE.SW cash_flow (annual, 2024-12-31) — Repayment Of Debt: -7276703823.63
JCARE.SW cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -2983506195.35
JCARE.SW income_statement (annual, 2024-12-31) — Research And Development: 1435351627.65
JCARE.SW income_statement (quarterly, 2024-12-31) — Research And Development: 398975317.59
JCARE.SW balance_sheet (annual, 2024-12-31) — Retained Earnings: 10491692921.28
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 10491692921.28
JCARE.SW cash_flow (annual, 2024-12-31) — Sale Of Investment: 1144639978.33
JCARE.SW cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 438379313.59
JCARE.SW cash_flow (annual, 2024-12-31) — Sale Of PPE: 1499554.67
JCARE.SW cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 1025424.67
JCARE.SW income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 3272792611.68
JCARE.SW income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 321733323.78
JCARE.SW income_statement (annual, 2024-12-31) — Selling General And Administration: 3547381244.77
JCARE.SW income_statement (quarterly, 2024-12-31) — Selling General And Administration: -112407660.97
JCARE.SW balance_sheet (annual, 2024-12-31) — Share Issued: 1874200420.00
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Share Issued: 1874200420.00
JCARE.SW income_statement (annual, 2024-12-31) — Special Income Charges: -255143686.01
JCARE.SW income_statement (quarterly, 2024-12-31) — Special Income Charges: -140282003.44
JCARE.SW balance_sheet (annual, 2024-12-31) — Stockholders Equity: 14534719589.34
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 14534719589.34
JCARE.SW balance_sheet (annual, 2024-12-31) — Tangible Book Value: 12848245634.46
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 12848245634.46
JCARE.SW income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -43675656.58
JCARE.SW income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -39108866.01
JCARE.SW income_statement (annual, 2024-12-31) — Tax Provision: 592140657.73
JCARE.SW income_statement (quarterly, 2024-12-31) — Tax Provision: 206522314.62
JCARE.SW income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.17
JCARE.SW income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.27
JCARE.SW cash_flow (annual, 2024-12-31) — Taxes Refund Paid Direct: -1865035473.13
JCARE.SW cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid Direct: -486275565.27
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Assets: 35718129456.13
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Assets: 35718129456.13
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Capitalization: 16959354701.71
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 16959354701.71
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Debt: 5295586923.50
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Debt: 5295586923.50
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 23400142779.28
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 23400142779.28
JCARE.SW income_statement (annual, 2024-12-31) — Total Expenses: 12096903965.00
JCARE.SW income_statement (quarterly, 2024-12-31) — Total Expenses: 2993436622.34
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 12317986676.85
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 12317986676.85
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 12712268478.82
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 12712268478.82
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3047203625.16
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3047203625.16
JCARE.SW income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 3616283726.11
JCARE.SW income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 783900628.42
JCARE.SW income_statement (annual, 2024-12-31) — Total Other Finance Cost: 14929903.19
JCARE.SW income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -30113335.26
JCARE.SW balance_sheet (annual, 2024-12-31) — Total Tax Payable: 263380339.80
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 263380339.80
JCARE.SW income_statement (annual, 2024-12-31) — Total Unusual Items: -263679785.18
JCARE.SW income_statement (quarterly, 2024-12-31) — Total Unusual Items: -143081658.99
JCARE.SW income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -263679785.18
JCARE.SW income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -143081658.99
JCARE.SW balance_sheet (annual, 2024-12-31) — Treasury Stock: 328221279.42
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 328221279.42
JCARE.SW balance_sheet (annual, 2024-12-31) — Work In Process: 765233042.09
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Work In Process: 765233042.09
JCARE.SW balance_sheet (annual, 2024-12-31) — Working Capital: 13735077925.62
JCARE.SW balance_sheet (quarterly, 2024-12-31) — Working Capital: 13735077925.62
JCARE.SW income_statement (annual, 2024-12-31) — Write Off: 7262094.01
JCARE.SW income_statement (quarterly, 2024-12-31) — Write Off: 6464883.18
JCARE.SW income_statement (quarterly, 2025-03-31) — +Operating Expense: 1467765171.74
JCARE.SW income_statement (quarterly, 2025-03-31) — +Total Revenue: 4089279479.56
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2090928550.79
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2590448694.38
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 54029237.68
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 1045060325.74
JCARE.SW income_statement (quarterly, 2025-03-31) — Basic Average Shares: 189473186.00
JCARE.SW income_statement (quarterly, 2025-03-31) — Basic EPS: 2.30
JCARE.SW cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 14842645678.32
JCARE.SW cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -187092618.94
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 24381306.38
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 14868082041.74
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14936401878.77
JCARE.SW cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -15554142.24
JCARE.SW cash_flow (quarterly, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: 809939509.20
JCARE.SW cash_flow (quarterly, 2025-03-31) — Changes In Cash: 34626519.50
JCARE.SW cash_flow (quarterly, 2025-03-31) — Classesof Cash Payments: -3139014950.72
JCARE.SW cash_flow (quarterly, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 4374377744.35
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Common Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 14644945685.41
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 569297560.98
JCARE.SW income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1558416030.26
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Current Assets: 23037766251.06
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Current Debt: 2325000000.00
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2760326452.44
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 8769730237.69
JCARE.SW income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 189473186.00
JCARE.SW income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.30
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 9845887.63
JCARE.SW income_statement (quarterly, 2025-03-31) — EBIT: 1174016739.22
JCARE.SW income_statement (quarterly, 2025-03-31) — EBITDA: 1174016739.22
JCARE.SW cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -18521599.72
JCARE.SW cash_flow (quarterly, 2025-03-31) — End Cash Position: 14858750598.10
JCARE.SW cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -514552145.74
JCARE.SW cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 622846890.26
JCARE.SW income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 220886435.03
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Goodwill: 636339503.82
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1696186832.87
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6222284495.62
JCARE.SW income_statement (quarterly, 2025-03-31) — Gross Profit: 2530863449.30
JCARE.SW income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 6355971.69
JCARE.SW income_statement (quarterly, 2025-03-31) — Interest Expense: 22898186.53
JCARE.SW income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 22898186.53
JCARE.SW income_statement (quarterly, 2025-03-31) — Interest Income: 110971266.84
JCARE.SW income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 110971266.84
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Inventory: 2484790118.05
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19507537354.58
JCARE.SW cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -260760843.96
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Investment Properties: 15907108.71
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1045060325.74
JCARE.SW cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 782140000.00
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 24381306.38
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2537591669.17
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2561972975.55
JCARE.SW cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 782140000.00
JCARE.SW cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -766740000.00
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1456836093.88
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Minority Interest: 9209011326.83
JCARE.SW income_statement (quarterly, 2025-03-31) — Minority Interests: -525335444.94
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Income: 435788328.07
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 435788328.07
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 961123773.01
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 435788328.07
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 435788328.07
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 961123773.01
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Interest Income: 85689883.97
JCARE.SW cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -76389636.95
JCARE.SW cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 15400000.00
JCARE.SW cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 15400000.00
JCARE.SW income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 85689883.97
JCARE.SW cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -514353849.75
JCARE.SW cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 2320823.93
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Net PPE: 6222284495.62
JCARE.SW cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -186692030.94
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 12948758852.54
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 308141226.96
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 314240559.25
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 690479239.50
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 269005571.41
JCARE.SW income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1186929438.36
JCARE.SW income_statement (quarterly, 2025-03-31) — Normalized Income: 446569756.35
JCARE.SW income_statement (quarterly, 2025-03-31) — Operating Income: 1063098277.56
JCARE.SW income_statement (quarterly, 2025-03-31) — Operating Revenue: 4089279479.56
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1829453386.00
JCARE.SW cash_flow (quarterly, 2025-03-31) — Other Cash Paymentsfrom Operating Activities: -1064959931.17
JCARE.SW cash_flow (quarterly, 2025-03-31) — Other Cash Receiptsfrom Operating Activities: 144492768.78
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 767073714.55
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 5009110.74
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1059847329.05
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1296244781.80
JCARE.SW income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -892082.80
JCARE.SW income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 48498322.81
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Payable: 3570971782.80
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Properties: 5652986934.64
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1973039153.60
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 68319837.03
JCARE.SW income_statement (quarterly, 2025-03-31) — Other Special Charges: 86129.77
JCARE.SW income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Payables: 5919343151.88
JCARE.SW cash_flow (quarterly, 2025-03-31) — Paymentson Behalfof Employees: -939376195.58
JCARE.SW cash_flow (quarterly, 2025-03-31) — Paymentsto Suppliersfor Goodsand Services: -1134678823.97
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 231983454.03
JCARE.SW income_statement (quarterly, 2025-03-31) — Pretax Income: 1151118552.69
JCARE.SW cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -185644515.80
JCARE.SW cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -187092618.94
JCARE.SW cash_flow (quarterly, 2025-03-31) — Receiptsfrom Customers: 4229884975.57
JCARE.SW income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1558416030.26
JCARE.SW cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -766740000.00
JCARE.SW income_statement (quarterly, 2025-03-31) — Research And Development: 300357357.53
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 10927481249.35
JCARE.SW cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 109254878.85
JCARE.SW cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 400588.00
JCARE.SW income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 950570599.38
JCARE.SW income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1171457034.41
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Share Issued: 1829453386.00
JCARE.SW income_statement (quarterly, 2025-03-31) — Special Income Charges: -14622187.87
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 14644945685.41
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 12948758852.54
JCARE.SW income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -2131270.86
JCARE.SW income_statement (quarterly, 2025-03-31) — Tax Provision: 189994779.68
JCARE.SW income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.17
JCARE.SW cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid Direct: -425423284.43
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Assets: 35768906356.14
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 17182537354.58
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Debt: 5322299427.99
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 23853957012.24
JCARE.SW income_statement (quarterly, 2025-03-31) — Total Expenses: 3026181202.00
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11914949343.90
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 12731140105.08
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3145219106.21
JCARE.SW income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 1152010635.49
JCARE.SW income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 2383196.34
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 247596930.66
JCARE.SW income_statement (quarterly, 2025-03-31) — Total Unusual Items: -12912699.14
JCARE.SW income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -12912699.14
JCARE.SW balance_sheet (quarterly, 2025-03-31) — Working Capital: 14268036013.37
JCARE.SW income_statement (quarterly, 2025-03-31) — Write Off: 8180086.41
JCARE.SW income_statement (quarterly, 2025-06-30) — +Operating Expense: 1596176595.08
JCARE.SW income_statement (quarterly, 2025-06-30) — +Total Revenue: 3809048770.85
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1951827025.78
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2886227493.74
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -7087159904.38
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 632040043.65
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -85927997.06
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 54046737.68
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 1038766399.28
JCARE.SW cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 14858750598.10
JCARE.SW cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -301175403.98
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 21132611.94
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 14486328294.55
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 14976952475.86
JCARE.SW cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -204536434.33
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 125698728.61
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Cash Financial: 14360629565.94
JCARE.SW cash_flow (quarterly, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: 1116417148.90
JCARE.SW cash_flow (quarterly, 2025-06-30) — Changes In Cash: -358412544.79
JCARE.SW cash_flow (quarterly, 2025-06-30) — Classesof Cash Payments: -2775300323.20
JCARE.SW cash_flow (quarterly, 2025-06-30) — Classesof Cash Receiptsfrom Operating Activities: 4333570716.98
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Common Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 14645400560.24
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 582667379.81
JCARE.SW income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1426716545.69
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Current Assets: 23390878032.22
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Current Debt: 2130000000.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2669276416.15
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 9097550764.70
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 345350501.55
JCARE.SW income_statement (quarterly, 2025-06-30) — EBIT: 944451113.52
JCARE.SW income_statement (quarterly, 2025-06-30) — EBITDA: 944451113.52
JCARE.SW cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -24366730.28
JCARE.SW cash_flow (quarterly, 2025-06-30) — End Cash Position: 14475971323.03
JCARE.SW cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1094116852.07
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Finished Goods: 859006996.95
JCARE.SW cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 815241744.92
JCARE.SW income_statement (quarterly, 2025-06-30) — General And Administrative Expense: -125079880.49
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Goodwill: 636339503.82
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1823708838.38
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 2972155490.80
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Gross PPE: 13219165113.74
JCARE.SW income_statement (quarterly, 2025-06-30) — Gross Profit: 2382332225.16
JCARE.SW income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 8458089.79
JCARE.SW income_statement (quarterly, 2025-06-30) — Interest Expense: 22827640.75
JCARE.SW income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 22827640.75
JCARE.SW income_statement (quarterly, 2025-06-30) — Interest Income: 135099529.12
JCARE.SW income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 135099529.12
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: 0.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Inventory: 2320707668.36
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Invested Capital: 19060964049.26
JCARE.SW cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -380712841.62
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Investment Properties: 15696887.85
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 1038766399.28
JCARE.SW cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1160000000.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 21132611.94
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2285563489.02
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2306696100.96
JCARE.SW cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1160000000.00
JCARE.SW cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1497781809.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1476173277.79
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 6725943086.83
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Minority Interest: 8891214149.63
JCARE.SW income_statement (quarterly, 2025-06-30) — Minority Interests: -453439440.63
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Income: 349151585.27
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 349151585.27
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 802591025.90
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 349151585.27
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 349151585.27
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 802591025.90
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Interest Income: 111191255.93
JCARE.SW cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -102803548.05
JCARE.SW cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -337781809.00
JCARE.SW cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -337781809.00
JCARE.SW income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 111191255.93
JCARE.SW cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -72990353.35
JCARE.SW cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -6762874.59
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Net PPE: 6132005209.36
JCARE.SW cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -271146418.98
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 12821691721.86
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 295705771.54
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 339400325.35
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 762906657.86
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 271953381.12
JCARE.SW income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 969572414.19
JCARE.SW income_statement (quarterly, 2025-06-30) — Normalized Income: 371028339.79
JCARE.SW income_statement (quarterly, 2025-06-30) — Operating Income: 786155630.08
JCARE.SW income_statement (quarterly, 2025-06-30) — Operating Revenue: 3809048770.85
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1829453386.00
JCARE.SW cash_flow (quarterly, 2025-06-30) — Other Cash Paymentsfrom Operating Activities: -1112656370.05
JCARE.SW cash_flow (quarterly, 2025-06-30) — Other Cash Receiptsfrom Operating Activities: 197554344.42
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1190088952.30
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 6492734.60
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1187369334.56
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Inventories: 107541946.78